학술논문
Multicenter phase II trial of trastuzumab deruxtecan for HER2-positive unresectable or recurrent biliary tract cancer: HERB trial
Document Type
Article
Author
Source
In: Future Oncology . (Future Oncology, June 2022, 18(19))
Subject
Language
English
ISSN
17448301
14796694
14796694